• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TGFβ 诱导的 c-Myb 影响 EMT 相关基因的表达并促进 ER+乳腺癌细胞的侵袭。

TGFβ-induced c-Myb affects the expression of EMT-associated genes and promotes invasion of ER+ breast cancer cells.

机构信息

ENEA Research Center Casaccia, Laboratory of Radiation Biology and Biomedicine, Casaccia, Rome, Italy.

出版信息

Cell Cycle. 2011 Dec 1;10(23):4149-61. doi: 10.4161/cc.10.23.18346.

DOI:10.4161/cc.10.23.18346
PMID:22101269
Abstract

Advanced breast cancer cells acquire metastatic properties in response to TGFβ. We show here that the expression of c-Myb increases in TGFβ-treated ER (+) breast cancer cells by protein stabilization, transcription activation and release from miR200-dependent down-regulation. In particular, we mapped 2 sites for miR200b, miR200c and miR429 binding in the 3' UTR of the human c-myb gene. These microRNAs decreased the expression of c-Myb when transfected in MCF-7 cells. In addition, luciferase activity from a vector containing the 3' UTR of the c-myb gene was inhibited by miR200s through a binding-dependent mechanism. siRNA- and shRNA-mediated down-regulation was used to investigate the role of c-Myb for the effects induced by TGFβ in ER(+) breast cancer MCF-7 and ZR-75.1 cells. Transfection with c-Myb siRNAs blocked the increase of Slug (SNAI2) and Bcl-2 expression and reversed the decrease in E-cadherin expression induced by TGF-β treatment. Conversely, c-Myb down-regulation decreased invasion and anchorage-independent growth of breast cancer cells expressing a constitutively active TGFβ receptor I. Finally, apoptosis induced by etoposide increased in c-Myb-silenced TGFβ-treated ER(+) cell lines. In summary, exposure of ER(+) breast cancer cells to TGFβ induces an increase of c-Myb expression which is required for expression of EMT-associated markers, in vitro invasion and anchorage-independent growth. Furthermore, our findings suggest a potentially detrimental effect of TGFβ and c-Myb co-expression in breast cancer.

摘要

晚期乳腺癌细胞在 TGFβ 的作用下获得转移特性。我们在这里表明,c-Myb 的表达在 TGFβ 处理的 ER(+)乳腺癌细胞中通过蛋白稳定、转录激活和 miR200 依赖性下调而增加。特别是,我们在人 c-myb 基因的 3'UTR 中映射了 2 个 miR200b、miR200c 和 miR429 结合的位点。这些 microRNAs 在 MCF-7 细胞中转染时降低了 c-Myb 的表达。此外,含有 c-myb 基因 3'UTR 的载体的荧光素酶活性通过结合依赖性机制被 miR200s 抑制。siRNA 和 shRNA 介导的下调用于研究 c-Myb 在 ER(+)乳腺癌 MCF-7 和 ZR-75.1 细胞中 TGFβ 诱导的作用的作用。c-Myb siRNAs 的转染阻断了 Slug(SNAI2)和 Bcl-2 表达的增加,并逆转了 TGF-β 处理诱导的 E-钙粘蛋白表达的减少。相反,c-Myb 的下调降低了表达组成型激活 TGFβ 受体 I 的乳腺癌细胞的侵袭和非锚定依赖性生长。最后,c-Myb 沉默的 TGFβ 处理的 ER(+)细胞系中依托泊苷诱导的细胞凋亡增加。总之,ER(+)乳腺癌细胞暴露于 TGFβ 会诱导 c-Myb 表达增加,这是 EMT 相关标志物表达、体外侵袭和非锚定依赖性生长所必需的。此外,我们的研究结果表明 TGFβ 和 c-Myb 共表达在乳腺癌中可能具有潜在的有害作用。

相似文献

1
TGFβ-induced c-Myb affects the expression of EMT-associated genes and promotes invasion of ER+ breast cancer cells.TGFβ 诱导的 c-Myb 影响 EMT 相关基因的表达并促进 ER+乳腺癌细胞的侵袭。
Cell Cycle. 2011 Dec 1;10(23):4149-61. doi: 10.4161/cc.10.23.18346.
2
Activation of miR200 by c-Myb depends on ZEB1 expression and miR200 promoter methylation.c-Myb 通过 ZEB1 表达和 miR200 启动子甲基化激活 miR200。
Cell Cycle. 2013 Jul 15;12(14):2309-20. doi: 10.4161/cc.25405.
3
Direct repression of MYB by ZEB1 suppresses proliferation and epithelial gene expression during epithelial-to-mesenchymal transition of breast cancer cells.在乳腺癌细胞上皮-间质转化过程中,ZEB1对MYB的直接抑制作用可抑制细胞增殖并抑制上皮基因表达。
Breast Cancer Res. 2013 Nov 27;15(6):R113. doi: 10.1186/bcr3580.
4
PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.PARP3通过刺激转谷氨酰胺酶2-蜗牛-E-钙黏蛋白轴来控制转化生长因子β和活性氧驱动的上皮-间质转化及干性。
Oncotarget. 2016 Sep 27;7(39):64109-64123. doi: 10.18632/oncotarget.11627.
5
ShRNA-mediated gene silencing of MTA1 influenced on protein expression of ER alpha, MMP-9, CyclinD1 and invasiveness, proliferation in breast cancer cell lines MDA-MB-231 and MCF-7 in vitro.shRNA 介导的 MTA1 基因沉默对乳腺癌细胞系 MDA-MB-231 和 MCF-7 中 ERα、MMP-9、CyclinD1 和侵袭性、增殖的蛋白表达的影响。
J Exp Clin Cancer Res. 2011 May 19;30(1):60. doi: 10.1186/1756-9966-30-60.
6
MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer.miR-155 介导的 C/EBPβ 缺失使 TGF-β 反应从生长抑制转变为乳腺癌中的上皮间质转化、浸润和转移。
Oncogene. 2013 Dec 12;32(50):5614-24. doi: 10.1038/onc.2013.322. Epub 2013 Aug 19.
7
Benzyl isothiocyanate inhibits epithelial-mesenchymal transition in cultured and xenografted human breast cancer cells.苄基异硫氰酸酯抑制培养和异种移植的人乳腺癌细胞中的上皮间质转化。
Cancer Prev Res (Phila). 2011 Jul;4(7):1107-17. doi: 10.1158/1940-6207.CAPR-10-0306. Epub 2011 Apr 4.
8
CDK9 inhibitors selectively target estrogen receptor-positive breast cancer cells through combined inhibition of MYB and MCL-1 expression.细胞周期蛋白依赖性激酶9(CDK9)抑制剂通过联合抑制MYB和MCL-1的表达,选择性地靶向雌激素受体阳性乳腺癌细胞。
Oncotarget. 2016 Feb 23;7(8):9069-83. doi: 10.18632/oncotarget.6997.
9
miR-200 affects tamoxifen resistance in breast cancer cells through regulation of MYB.miR-200 通过调控 MYB 影响乳腺癌细胞对他莫昔芬的耐药性。
Sci Rep. 2019 Dec 11;9(1):18844. doi: 10.1038/s41598-019-54289-6.
10
Expression of Slug is regulated by c-Myb and is required for invasion and bone marrow homing of cancer cells of different origin.Slug 的表达受 c-Myb 调控,对于不同来源的癌细胞的侵袭和骨髓归巢是必需的。
J Biol Chem. 2010 Sep 17;285(38):29434-45. doi: 10.1074/jbc.M109.089045. Epub 2010 Jul 11.

引用本文的文献

1
Revisiting Treatment Strategies: Addressing Epithelial-to-Mesenchymal Transition-Induced Resistance in Hepatocellular Carcinoma.重新审视治疗策略:应对肝细胞癌中上皮-间质转化诱导的耐药性
BME Front. 2025 Jun 24;6:0144. doi: 10.34133/bmef.0144. eCollection 2025.
2
Non-coding RNAs, a double-edged sword in breast cancer prognosis.非编码RNA,乳腺癌预后中的一把双刃剑。
Cancer Cell Int. 2025 Apr 1;25(1):123. doi: 10.1186/s12935-025-03679-0.
3
From modulation of cellular plasticity to potentiation of therapeutic resistance: new and emerging roles of MYB transcription factors in human malignancies.
从细胞可塑性的调节到治疗抵抗的增强:MYB 转录因子在人类恶性肿瘤中的新出现作用。
Cancer Metastasis Rev. 2024 Mar;43(1):409-421. doi: 10.1007/s10555-023-10153-8. Epub 2023 Nov 10.
4
Transcription factor c-Myb: novel prognostic factor in osteosarcoma.转录因子 c-Myb:骨肉瘤的新型预后因素。
Clin Exp Metastasis. 2022 Apr;39(2):375-390. doi: 10.1007/s10585-021-10145-4. Epub 2022 Jan 7.
5
The miR-200 Family of microRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers.微小RNA的miR-200家族:上皮-间质转化的精细调节因子及循环肿瘤生物标志物
Cancers (Basel). 2021 Nov 23;13(23):5874. doi: 10.3390/cancers13235874.
6
Reversing an Oncogenic Epithelial-to-Mesenchymal Transition Program in Breast Cancer Reveals Actionable Immune Suppressive Pathways.逆转乳腺癌中的致癌上皮-间质转化程序揭示了可操作的免疫抑制途径。
Pharmaceuticals (Basel). 2021 Nov 2;14(11):1122. doi: 10.3390/ph14111122.
7
Integration in oncogenes plays only a minor role in determining the in vivo distribution of HIV integration sites before or during suppressive antiretroviral therapy.整合入癌基因在决定 HIV 整合位点在抑制性抗逆转录病毒治疗之前或期间的体内分布方面仅起次要作用。
PLoS Pathog. 2021 Apr 7;17(4):e1009141. doi: 10.1371/journal.ppat.1009141. eCollection 2021 Apr.
8
c-Myb interferes with inflammatory IL1α-NF-κB pathway in breast cancer cells.c-Myb 干扰乳腺癌细胞中的炎症性 IL1α-NF-κB 通路。
Neoplasia. 2021 Mar;23(3):326-336. doi: 10.1016/j.neo.2021.01.002. Epub 2021 Feb 20.
9
Zinc Gluconate Induces Potentially Cancer Chemopreventive Activity in Barrett's Esophagus: A Phase 1 Pilot Study.葡萄糖酸锌诱导巴雷特食管潜在的癌症化学预防活性:一项 1 期初步研究。
Dig Dis Sci. 2021 Apr;66(4):1195-1211. doi: 10.1007/s10620-020-06319-x. Epub 2020 May 15.
10
miR-200 affects tamoxifen resistance in breast cancer cells through regulation of MYB.miR-200 通过调控 MYB 影响乳腺癌细胞对他莫昔芬的耐药性。
Sci Rep. 2019 Dec 11;9(1):18844. doi: 10.1038/s41598-019-54289-6.